Download PDF
Semin intervent Radiol 2019; 36(03): 163-175
DOI: 10.1055/s-0039-1693981
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Lung Ablation: Indications and Techniques

Bashir Akhavan Tafti
1   Divisions of Interventional Radiology, David Geffen School of Medicine, UCLA Health System, Los Angeles, California
,
Scott Genshaft
2   Thoracic Imaging at the Department of Radiological Sciences, David Geffen School of Medicine, UCLA Health System, Los Angeles, California
,
Robert Suh
1   Divisions of Interventional Radiology, David Geffen School of Medicine, UCLA Health System, Los Angeles, California
2   Thoracic Imaging at the Department of Radiological Sciences, David Geffen School of Medicine, UCLA Health System, Los Angeles, California
,
Fereidoun Abtin
1   Divisions of Interventional Radiology, David Geffen School of Medicine, UCLA Health System, Los Angeles, California
2   Thoracic Imaging at the Department of Radiological Sciences, David Geffen School of Medicine, UCLA Health System, Los Angeles, California
› Author Affiliations
Further Information

Publication History

Publication Date:
19 August 2019 (online)

Also available at
   Permissions and Reprints

Abstract

Lung ablation is ever more recognized since its initial report and use almost two decades ago. With technological advancements in thermal modalities, particularly microwave ablation and cryoablation, better identification of the cohort of patients who best benefit from ablation, and understanding the role of imaging after ablation, image-guided thermal ablation for primary and secondary pulmonary malignancies is increasingly recognized and accepted as a cogent form of local therapy.

Keywords

interventional radiology - lung - lung cancer - ablation
 

  • References

  • 1 Dupuy DE, Zagoria RJ, Akerley W, Mayo-Smith WW, Kavanagh PV, Safran H. Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol 2000; 174 (01) 57-59
    CrossrefPubMedGoogle Scholar
  • 2 Rosenberg C, Puls R, Hegenscheid K. , et al. Laser ablation of metastatic lesions of the lung: long-term outcome. AJR Am J Roentgenol 2009; 192 (03) 785-792
    CrossrefPubMedGoogle Scholar
  • 3 Usman M, Moore W, Talati R, Watkins K, Bilfinger TV. Irreversible electroporation of lung neoplasm: a case series. Med Sci Monit 2012; 18 (06) CS43-CS47
    PubMedGoogle Scholar
  • 4 Ricke J, Jürgens JH, Deschamps F. , et al. Irreversible electroporation (IRE) fails to demonstrate efficacy in a prospective multicenter phase II trial on lung malignancies: the ALICE trial. Cardiovasc Intervent Radiol 2015; 38 (02) 401-408
    CrossrefPubMedGoogle Scholar
  • 5 Wright AS, Sampson LA, Warner TF, Mahvi DM, Lee Jr FT. Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology 2005; 236 (01) 132-139
    CrossrefPubMedGoogle Scholar
  • 6 Hong K, Georgiades C. Radiofrequency ablation: mechanism of action and devices. J Vasc Interv Radiol 2010; 21 (8, Suppl): S179-S186
    CrossrefPubMedGoogle Scholar
  • 7 Brace CL. Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences?. Curr Probl Diagn Radiol 2009; 38 (03) 135-143
    CrossrefPubMedGoogle Scholar
  • 8 Sun Y, Wang Y, Ni X. , et al. Comparison of ablation zone between 915- and 2,450-MHz cooled-shaft microwave antenna: results in in vivo porcine livers. AJR Am J Roentgenol 2009; 192 (02) 511-514
    CrossrefPubMedGoogle Scholar
  • 9 Lubner MG, Brace CL, Hinshaw JL, Lee Jr FT. Microwave tumor ablation: mechanism of action, clinical results, and devices. J Vasc Interv Radiol 2010; 21 (8, Suppl): S192-S203
    CrossrefPubMedGoogle Scholar
  • 10 Hinshaw JL, Lubner MG, Ziemlewicz TJ, Lee Jr FT, Brace CL. Percutaneous tumor ablation tools: microwave, radiofrequency, or cryoablation--what should you use and why?. Radiographics 2014; 34 (05) 1344-1362
    CrossrefPubMedGoogle Scholar
  • 11 Gage AA, Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology 1998; 37 (03) 171-186
    CrossrefPubMedGoogle Scholar
  • 12 Baust JG, Gage AA. Progress toward optimization of cryosurgery. Technol Cancer Res Treat 2004; 3 (02) 95-101
    CrossrefPubMedGoogle Scholar
  • 13 Cooper IS. Cryobiology as viewed by the surgeon. Cryobiology 1964; 51: 44-51
    PubMedGoogle Scholar
  • 14 Li G, Xue M, Chen W, Yi S. Efficacy and safety of radiofrequency ablation for lung cancers: a systematic review and meta-analysis. Eur J Radiol 2018; 100: 92-98
    CrossrefPubMedGoogle Scholar
  • 15 Dupuy DE, Fernando HC, Hillman S. , et al. Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial. Cancer 2015; 121 (19) 3491-3498
    CrossrefPubMedGoogle Scholar
  • 16 Palussière J, Chomy F, Savina M. , et al. Radiofrequency ablation of stage IA non-small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial. J Cardiothorac Surg 2018; 13 (01) 91
    CrossrefPubMedGoogle Scholar
  • 17 Howington JA, Blum MG, Chang AC, Balekian AA, Murthy SC. Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013; 143 (5, Suppl): e278S-e313S
    CrossrefPubMedGoogle Scholar
  • 18 Kodama H, Yamakado K, Takaki H. , et al. Lung radiofrequency ablation for the treatment of unresectable recurrent non-small-cell lung cancer after surgical intervention. Cardiovasc Intervent Radiol 2012; 35 (03) 563-569
    CrossrefPubMedGoogle Scholar
  • 19 Macchi M, Belfiore MP, Floridi C. , et al. Radiofrequency versus microwave ablation for treatment of the lung tumours: LUMIRA (lung microwave radiofrequency) randomized trial. Med Oncol 2017; 34 (05) 96
    CrossrefPubMedGoogle Scholar
  • 20 Vogl TJ, Nour-Eldin NA, Albrecht MH. , et al. Thermal ablation of lung tumors: focus on microwave ablation. RoFo Fortschr Geb Rontgenstr Nuklearmed 2017; 189 (09) 828-843
    Article in Thieme ConnectPubMedGoogle Scholar
  • 21 Tsakok MT, Jones D, MacNeill A, Gleeson FV. Is microwave ablation more effective than radiofrequency ablation in achieving local control for primary pulmonary malignancy?. Interact Cardiovasc Thorac Surg 2019; ivz044
    PubMedGoogle Scholar
  • 22 Moore W, Talati R, Bhattacharji P, Bilfinger T. Five-year survival after cryoablation of stage I non-small cell lung cancer in medically inoperable patients. J Vasc Interv Radiol 2015; 26 (03) 312-319
    CrossrefPubMedGoogle Scholar
  • 23 McDevitt JL, Mouli SK, Nemcek AA, Lewandowski RJ, Salem R, Sato KT. Percutaneous cryoablation for the treatment of primary and metastatic lung tumors: identification of risk factors for recurrence and major complications. J Vasc Interv Radiol 2016; 27 (09) 1371-1379
    CrossrefPubMedGoogle Scholar
  • 24 Lam A, Yoshida EJ, Bui K, Fernando D, Nelson K, Abi-Jaoudeh N. A national cancer database analysis of radiofrequency ablation versus stereotactic body radiotherapy in early-stage non-small cell lung cancer. J Vasc Interv Radiol 2018; 29 (09) 1211-1217.e1
    CrossrefPubMedGoogle Scholar
  • 25 Chan MD, Dupuy DE, Mayo-Smith WW, Ng T, DiPetrillo TA. Combined radiofrequency ablation and high-dose rate brachytherapy for early-stage non-small-cell lung cancer. Brachytherapy 2011; 10 (03) 253-259
    CrossrefPubMedGoogle Scholar
  • 26 Grieco CA, Simon CJ, Mayo-Smith WW, DiPetrillo TA, Ready NE, Dupuy DE. Percutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancer. J Vasc Interv Radiol 2006; 17 (07) 1117-1124
    CrossrefPubMedGoogle Scholar
  • 27 Kim SR, Han HJ, Park SJ. , et al. Comparison between surgery and radiofrequency ablation for stage I non-small cell lung cancer. Eur J Radiol 2012; 81 (02) 395-399
    CrossrefPubMedGoogle Scholar
  • 28 Kwan SW, Mortell KE, Hippe DS, Brunner MC. An economic analysis of sublobar resection versus thermal ablation for early-stage non-small-cell lung cancer. J Vasc Interv Radiol 2014; 25 (10) 1558-1564 , quiz 1565
    CrossrefPubMedGoogle Scholar
  • 29 Zemlyak A, Moore WH, Bilfinger TV. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer. J Am Coll Surg 2010; 211 (01) 68-72
    CrossrefPubMedGoogle Scholar
  • 30 Lee H, Jin GY, Han YM. , et al. Comparison of survival rate in primary non-small-cell lung cancer among elderly patients treated with radiofrequency ablation, surgery, or chemotherapy. Cardiovasc Intervent Radiol 2012; 35 (02) 343-350
    CrossrefPubMedGoogle Scholar
  • 31 Crabtree T, Puri V, Timmerman R. , et al. Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033). J Thorac Cardiovasc Surg 2013; 145 (03) 692-699
    CrossrefPubMedGoogle Scholar
  • 32 Alexander ES, Machan JT, Ng T, Breen LD, DiPetrillo TA, Dupuy DE. Cost and effectiveness of radiofrequency ablation versus limited surgical resection for stage I non-small-cell lung cancer in elderly patients: is less more?. J Vasc Interv Radiol 2013; 24 (04) 476-482
    CrossrefPubMedGoogle Scholar
  • 33 Mouli SK, Kurilova I, Sofocleous CT, Lewandowski RJ. The role of percutaneous image-guided thermal ablation for the treatment of pulmonary malignancies. AJR Am J Roentgenol 2017; 209 (04) 740-751
    CrossrefPubMedGoogle Scholar
  • 34 Vogl TJ, Naguib NN, Gruber-Rouh T, Koitka K, Lehnert T, Nour-Eldin NE. Microwave ablation therapy: clinical utility in treatment of pulmonary metastases. Radiology 2011; 261 (02) 643-651
    CrossrefPubMedGoogle Scholar
  • 35 de Baère T, Aupérin A, Deschamps F. , et al. Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases. Ann Oncol 2015; 26 (05) 987-991
    CrossrefPubMedGoogle Scholar
  • 36 Simon CJ, Dupuy DE, DiPetrillo TA. , et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 2007; 243 (01) 268-275
    CrossrefPubMedGoogle Scholar
  • 37 Yamakado K, Inoue Y, Takao M. , et al. Long-term results of radiofrequency ablation in colorectal lung metastases: single center experience. Oncol Rep 2009; 22 (04) 885-891
    PubMedGoogle Scholar
  • 38 Okuma T, Matsuoka T, Yamamoto A. , et al. Determinants of local progression after computed tomography-guided percutaneous radiofrequency ablation for unresectable lung tumors: 9-year experience in a single institution. Cardiovasc Intervent Radiol 2010; 33 (04) 787-793
    CrossrefPubMedGoogle Scholar
  • 39 Chua TC, Sarkar A, Saxena A, Glenn D, Zhao J, Morris DL. Long-term outcome of image-guided percutaneous radiofrequency ablation of lung metastases: an open-labeled prospective trial of 148 patients. Ann Oncol 2010; 21 (10) 2017-2022
    CrossrefPubMedGoogle Scholar
  • 40 de Baere T, Tselikas L, Woodrum D. , et al. Evaluating cryoablation of metastatic lung tumors in patients--safety and efficacy: the ECLIPSE trial--interim analysis at 1 year. J Thorac Oncol 2015; 10 (10) 1468-1474
    CrossrefPubMedGoogle Scholar
  • 41 Aziz A, Ashizawa K, Nagaoki K, Hayashi K. High resolution CT anatomy of the pulmonary fissures. J Thorac Imaging 2004; 19 (03) 186-191
    CrossrefPubMedGoogle Scholar
  • 42 Al-Hakim RA, Abtin FG, Genshaft SJ, Kutay E, Suh RD. Defining new metrics in microwave ablation of pulmonary tumors: ablation work and ablation resistance score. J Vasc Interv Radiol 2016; 27 (09) 1380-1386
    CrossrefPubMedGoogle Scholar
  • 43 Nakatsuka S, Yashiro H, Inoue M. , et al. On freeze-thaw sequence of vital organ of assuming the cryoablation for malignant lung tumors by using cryoprobe as heat source. Cryobiology 2010; 61 (03) 317-326
    CrossrefPubMedGoogle Scholar
  • 44 Hinshaw JL, Littrup PJ, Durick N. , et al. Optimizing the protocol for pulmonary cryoablation: a comparison of a dual- and triple-freeze protocol. Cardiovasc Intervent Radiol 2010; 33 (06) 1180-1185
    CrossrefPubMedGoogle Scholar
  • 45 Pan PJ, Bansal AK, Genshaft SJ, Kim GH, Suh RD, Abtin F. Comparison of double-freeze versus modified triple-freeze pulmonary cryoablation and hemorrhage volume using different probe sizes in an in vivo porcine lung. J Vasc Interv Radiol 2018; 29 (05) 722-728
    CrossrefPubMedGoogle Scholar
  • 46 Littrup PJ, Mody A, Sparschu R. , et al. Prostatic cryotherapy: ultrasonographic and pathologic correlation in the canine model. Urology 1994; 44 (02) 175-183 , discussion 183–184
    CrossrefPubMedGoogle Scholar
  • 47 Abtin F, Quirk MT, Suh RD. , et al. Percutaneous cryoablation for the treatment of recurrent malignant pleural mesothelioma: safety, early-term efficacy, and predictors of local recurrence. J Vasc Interv Radiol 2017; 28 (02) 213-221
    CrossrefPubMedGoogle Scholar
  • 48 Abtin F, Suh RD, Nasehi L. , et al. Percutaneous cryoablation for the treatment of recurrent thymoma: preliminary safety and efficacy. J Vasc Interv Radiol 2015; 26 (05) 709-714
    CrossrefPubMedGoogle Scholar
  • 49 Sabel MS. Cryo-immunology: a review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses. Cryobiology 2009; 58 (01) 1-11
    CrossrefPubMedGoogle Scholar
  • 50 Wang H, Littrup PJ, Duan Y, Zhang Y, Feng H, Nie Z. Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. Radiology 2005; 235 (01) 289-298
    CrossrefPubMedGoogle Scholar
  • 51 Kawamura M, Izumi Y, Tsukada N. , et al. Percutaneous cryoablation of small pulmonary malignant tumors under computed tomographic guidance with local anesthesia for nonsurgical candidates. J Thorac Cardiovasc Surg 2006; 131 (05) 1007-1013
    CrossrefPubMedGoogle Scholar
  • 52 Shi F, Li G, Zhou Z. , et al. Microwave ablation versus radiofrequency ablation for the treatment of pulmonary tumors. Oncotarget 2017; 8 (65) 109791-109798
    CrossrefPubMedGoogle Scholar
  • 53 Vogl TJ, Eckert R, Naguib NN, Beeres M, Gruber-Rouh T, Nour-Eldin NA. Thermal ablation of colorectal lung metastases: retrospective comparison among laser-induced thermotherapy, radiofrequency ablation, and microwave ablation. AJR Am J Roentgenol 2016; 207 (06) 1340-1349
    CrossrefPubMedGoogle Scholar
  • 54 Planché O, Teriitehau C, Boudabous S. , et al. In vivo evaluation of lung microwave ablation in a porcine tumor mimic model. Cardiovasc Intervent Radiol 2013; 36 (01) 221-228
    CrossrefPubMedGoogle Scholar
  • 55 Skonieczki BD, Wells C, Wasser EJ, Dupuy DE. Radiofrequency and microwave tumor ablation in patients with implanted cardiac devices: is it safe?. Eur J Radiol 2011; 79 (03) 343-346
    CrossrefPubMedGoogle Scholar
  • 56 Kashima M, Yamakado K, Takaki H. , et al. Complications after 1000 lung radiofrequency ablation sessions in 420 patients: a single center's experiences. AJR Am J Roentgenol 2011; 197 (04) W576-80
    CrossrefPubMedGoogle Scholar
  • 57 Chan VO, McDermott S, Malone DE, Dodd JD. Percutaneous radiofrequency ablation of lung tumors: evaluation of the literature using evidence-based techniques. J Thorac Imaging 2011; 26 (01) 18-26
    CrossrefPubMedGoogle Scholar
  • 58 Zheng A, Wang X, Yang X. , et al. Major complications after lung microwave ablation: a single-center experience on 204 sessions. Ann Thorac Surg 2014; 98 (01) 243-248
    CrossrefPubMedGoogle Scholar
  • 59 Zhu JC, Yan TD, Morris DL. A systematic review of radiofrequency ablation for lung tumors. Ann Surg Oncol 2008; 15 (06) 1765-1774
    CrossrefPubMedGoogle Scholar
  • 60 Sakurai J, Hiraki T, Mukai T. , et al. Intractable pneumothorax due to bronchopleural fistula after radiofrequency ablation of lung tumors. J Vasc Interv Radiol 2007; 18 (1, Pt 1): 141-145
    CrossrefPubMedGoogle Scholar
  • 61 Kodama H, Yamakado K, Murashima S. , et al. Intractable bronchopleural fistula caused by radiofrequency ablation: endoscopic bronchial occlusion with silicone embolic material. Br J Radiol 2009; 82 (983) e225-e227
    CrossrefPubMedGoogle Scholar
  • 62 Powell DK, Baum S. Bronchopleural fistula treated with N-butyl cyanoacrylate glue after ablation. J Vasc Interv Radiol 2018; 29 (12) 1692-1693
    CrossrefPubMedGoogle Scholar
  • 63 Okuma T, Matsuoka T, Yamamoto A. , et al. Frequency and risk factors of various complications after computed tomography-guided radiofrequency ablation of lung tumors. Cardiovasc Intervent Radiol 2008; 31 (01) 122-130
    CrossrefPubMedGoogle Scholar
  • 64 Hiraki T, Tajiri N, Mimura H. , et al. Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: incidence and risk factors. Radiology 2006; 241 (01) 275-283
    CrossrefPubMedGoogle Scholar
  • 65 Abtin FG, Eradat J, Gutierrez AJ, Lee C, Fishbein MC, Suh RD. Radiofrequency ablation of lung tumors: imaging features of the postablation zone. Radiographics 2012; 32 (04) 947-969
    CrossrefPubMedGoogle Scholar